Risks and Benefits of Hormonal Manipulation as Monotherapy or Adjuvant Treatment in Localised Prostate Cancer

European Urology - Netherlands
doi 10.1016/j.eururo.2005.09.005
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Elsevier BV

Related search

Irinotecan Monotherapy as Third-Line or Later Treatment in Advanced Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2017English

Hormonal Manipulation of Prostatic Cancer.

BMJ
1991English

Systemic Complications in the Hormonal Treatment of Prostate and Breast Cancer

Nowotwory
Cancer ResearchOncology
2017English

Cardiovascular Risk During Hormonal Treatment in Patients With Prostate Cancer

Cancer Management and Research
Oncology
2011English

Adjuvant Chemotherapy in the Treatment of Clinically Localised Ewing's Sarcoma

The Journal of Bone and Joint Surgery. British volume
1978English

Beyond Castration—Defining Future Directions in the Hormonal Treatment of Prostate Cancer

Hormones and Cancer
OncologyCancer ResearchEndocrinologyAutonomic SystemsEndocrineMetabolismDiabetes
2011English

Metformin as an Adjuvant in Breast Cancer Treatment

SAGE Open Medicine
Medicine
2019English

Types of Chronic Conditions Combinations and Initial Cancer Treatment Among Elderly Medicare Beneficiaries With Localised Prostate Cancer

International Journal of Clinical Practice
Medicine
2016English

Patient-Reported Outcomes After Surgery or Radiotherapy for Localised Prostate Cancer: A Retrospective Study

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy